Investor Stock List
Ranked #1,232 of 8,699 institutional investors

BVF Inc/il

San Francisco, CA

$2.74B
US stock portfolio at live prices · today −$10.6M (−0.38%)
Market closed. Prices as of Nov 20, 6:41 AM ET
Value at quarter end (Q3 2026)
$3.04B
Change from Q2 2026
−$870.9M (−22.27%)
Positions
39 · 2 new, 0 sold out
Filed
Nov 16, 2026

Not counted in the ranking: none$483M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
KYMR 16.8%RVMD 14.3%XNCR 7.72%MLTX 6.43%STOK 3.54%
StockSharesValue, live% of portfoliovs Q2 2026
KYMR Kymera Therapeutics, Inc.3,872,052$462M16.8%Unchanged
RVMD Revolution Medicines, Inc.2,460,560$392M14.3%Reduced −17%
XNCR Xencor, Inc.6,227,034$212M7.72%Reduced −13%
MLTX MoonLake Immunotherapeutics16,001,284$176M6.43%Unchanged
STOK Stoke Therapeutics, Inc.3,608,968$97.2M3.54%Added +42%
ZYME Zymeworks Inc.3,464,142$93.0M3.39%Reduced −5%
PVLA Palvella Therapeutics, Inc.607,149$88.5M3.22%Reduced −10%
TYRA Tyra Biosciences, Inc.4,215,886$83.2M3.03%Added +186%
NKTR Nektar Therapeutics2,134,007$69.4M2.53%Reduced −11%
CGEM Cullinan Therapeutics, Inc.5,750,683$52.2M1.90%Unchanged
KURA Kura Oncology, Inc.6,690,108$49.2M1.79%Reduced −21%
GPCR Structure Therapeutics Inc.2,691,426$46.1M1.68%Reduced −20%
MIRM Mirum Pharmaceuticals, Inc.407,226$38.9M1.42%Reduced −61%
GLUE Monte Rosa Therapeutics, Inc.4,276,578$38.1M1.39%Reduced −4%
OLMA Olema Oncology, Inc.5,295,893$37.9M1.38%Unchanged
SGMT Sagimet Biosciences Inc.3,500,000$33.7M1.23%Added +40%
IMCR Immunocore Holdings plc1,230,909$32.8M1.19%Reduced −5%
FDMT 4D Molecular Therapeutics, Inc.2,879,289$30.9M1.12%Unchanged
ANNX Annexon, Inc.8,278,164$28.2M1.03%Reduced −5%
ALEC Alector, Inc.10,046,206$23.1M0.84%New
QTTB Q32 Bio Inc.2,350,000$19.9M0.73%Unchanged
PYXS Pyxis Oncology, Inc.11,826,140$19.9M0.72%New
ABSI Absci Corporation2,361,674$19.3M0.70%Unchanged
IRON Disc Medicine, Inc.233,300$17.8M0.65%Reduced −80%
AVR Anteris Technologies Global Corp.3,000,000$15.3M0.56%Unchanged
IVVD Invivyd, Inc.28,165,000$12.6M0.46%Unchanged
ELDN Eledon Pharmaceuticals, Inc.6,293,282$12.0M0.44%Unchanged
OKUR OnKure Therapeutics, Inc.4,045,278$11.2M0.41%Added +25%
STRO Sutro Biopharma, Inc.1,251,788$10.9M0.40%Unchanged
FHTX Foghorn Therapeutics Inc.5,842,000$10.4M0.38%Unchanged
AVTX Avalo Therapeutics, Inc.907,406$6.1M0.22%Reduced −56%
IMUX Immunic, Inc.765,295$5.7M0.21%Unchanged
XFOR X4 Pharmaceuticals, Inc.1,576,624$4.7M0.17%Reduced −29%
IMA ImageneBio, Inc.1,110,002$4.4M0.16%Unchanged
MOLN Molecular Partners AG1,353,968$3.6M0.13%Unchanged
IVA Inventiva S.A.686,040$2.4M<0.1%Unchanged
TCRX TScan Therapeutics, Inc.5,564,290$794K<0.1%Unchanged
ENGNW enGene Therapeutics Inc.945,402$152K<0.1%Unchanged
TENX Tenax Therapeutics, Inc.25,000$35K<0.1%Reduced −93%